Mr. Michael R. Minogue has been Chairman, President and Chief Executive Officer of Abiomed (NASDAQ: ABMD) since 2004. Mr. Minogue transitioned the company’s mission to creating the field of heart and lung recovery with the acquisition and development of technologies such as Impella®, the world’s smallest heart pump, and extracorporeal membrane oxygenation (ECMO). Abiomed has been one of the fastest growing, GAAP profitable medtech companies and ranked the third best performing stock on the S&P 500 for the last decade. Abiomed has earned numerous global regulatory approvals on products and indications in the United States, Europe, Japan and other countries. Abiomed employs approximately 1,700 people with facilities in Danvers, Massachusetts, Aachen and Berlin, Germany, Baltimore, Maryland, and Tokyo, Japan.
In addition to his responsibilities at Abiomed, Mr. Minogue currently serves as Chairman of the medical device industry association board of directors for AdvaMed and serves on the board for the Medical Device Innovation Consortium (MDIC). He also serves on Insulet Corporation's board of directors and was on the boards of LifeCell and Bioventus.
Before joining Abiomed, Mr. Minogue spent 11 years with General Electric Healthcare, where he held numerous leadership positions and holds three patents. Mr. Minogue also served as an officer in the U.S. Army, which included multiple distinctions including Airborne, Ranger, Desert Storm Veteran and Bronze Star. He received his Bachelor of Science degree in engineering management from the United States Military Academy at West Point and his Master of Business Administration from the University of Chicago.
Mr. Minogue cofounded the Mike and Renee Minogue Foundation and the Mentoring Veterans Program (MedTechVets), a 501(c)(3) nonprofit organization that helps military veterans network with industry mentors to discover career opportunities in the medtech industry. He serves on the board of directors after serving as Chairman for 8 years. Mr. Minogue is the Chairman of the Governor’s Advisory Council on Veterans’ Services for Massachusetts and supports the Inner-City Scholarship Fund, Boys and Girls Club, and multiple educational initiatives. Mr. Minogue is married with five children and enjoys reading, mentoring, running, coaching, skiing and playing sports.
What is Michael R. Minogue's net worth?
The estimated net worth of Michael R. Minogue is at least $90.16 million as of June 21st, 2021. Mr. Minogue owns 236,635 shares of Abiomed stock worth more than $90,162,668 as of November 18th. This net worth estimate does not reflect any other investments that Mr. Minogue may own. Additionally, Mr. Minogue receives a salary of $3,040,000.00 as CEO at Abiomed. Learn More about Michael R. Minogue's net worth.
How old is Michael R. Minogue?
What is Michael R. Minogue's salary?
How do I contact Michael R. Minogue?
Has Michael R. Minogue been buying or selling shares of Abiomed?
Who are Abiomed's active insiders?
Abiomed's insider roster includes Marc Began (VP), Andrew Greenfield (VP), Michael Minogue (CEO), Michael Minogue (CEO), Dorothy Puhy (Director), Joseph Riccelli, Sr. (CEO), Martin Sutter (Director), Paul Thomas (Director), Todd Trapp (CFO), David Weber (COO), and Magdalena Yesil (Director). Learn More on Abiomed's active insiders.